Adrian Kilcoyne's most recent trade in Celularity Inc - Ordinary Shares - Class A was a trade of 205,213 Stock Option Grant (Right to Buy) done . Disclosure was reported to the exchange on Feb. 16, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Celularity Inc - Ordinary ... | Kilcoyne Adrian | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 205,213 | 205,213 | - | - | Stock Option Grant (Right to Buy) | |
Celularity Inc - Ordinary ... | Adrian Kilcoyne | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. | 16 Feb 2024 | 52,762 | 1,122,238 | - | 0.4 | 22,899 | Class A Common Stock |
Celularity Inc - Ordinary ... | Adrian Kilcoyne | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 875,000 | 1,175,000 | - | 0 | Class A Common Stock | |
Celularity Inc - Ordinary ... | Adrian Kilcoyne | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 300,000 | 300,000 | - | - | Class A Common Stock |